Carla Luciani received her B.S in chemical engineer from Universidad Nacional de Mar del Plata in 2001 and PhD in Chemical Engineering from Universidad Nacional del Litoral in 2006. She spent 4 year at University of Maryland, initially as a postdoctoral fellow and then as a research professor. She published dozens of articles, a patent, and presented in numerous conferences in the field of polymer reaction engineering & modeling.
She joined Small Molecule Design and Development at Eli Lilly in 2011 as a process engineer. In 2014, she joined the process design and development group as the leader of the drug substance M&S group. In that role, she guided a group of chemical engineers and developed models for hybrid and continuous drug substance processes. She became an engineer advisor in 2016 and the leader of Future Manufacturing Platforms innovation capability. Future manufacturing platform team main objective was to identify, design, develop and test new manufacturing platforms and ensure that chemistry, formulation, engineering and analytical solutions can meet future manufacturing needs for both drug substance and drug product for synthetic molecules (inducing small molecules and novel modalities). In this role, she has supported innovation by identifying new technologies, helped established collaborations, and promoted the implementation of innovation for the manufacturing. She is currently the head of RNA-therapeutics at Lilly Cambridge Innovation Center
At AIChE, she is currently the Chief Newsletter Editor of Pharmaceutical Discovery, Development and Manufacturing Forum Newsletter and the leader of the Membership.